EIF5A2 Matched Antibody Pair (372) (APMAB-372LY)

Zhang, Z., He, G., Lv, Y., Liu, Y., Niu, Z., Feng, Q., ... & Xu, J. (2022). HERC3 regulates epithelial-mesenchymal transition by directly ubiquitination degradation EIF5A2 and inhibits metastasis of colorectal cancer. Cell death & disease, 13(1), 1-12.

Zhao, G., Zhang, W., Dong, P., Watari, H., Guo, Y., Pfeffer, L. M., ... & Yue, J. (2021). EIF5A2 controls ovarian tumor growth and metastasis by promoting epithelial to mesenchymal transition via the TGFβ pathway. Cell & bioscience, 11(1), 1-12.

Zheng, Y., Li, P., Huang, H., Ye, X., Chen, W., Xu, G., & Zhang, F. (2021). Androgen receptor regulates eIF5A2 expression and promotes prostate cancer metastasis via EMT. Cell death discovery, 7(1), 1-8.

Luan, W., Ding, Y., Yuan, H., Ma, S., Ruan, H., Wang, J., ... & Bu, X. (2020). Long non-coding RNA LINC00520 promotes the proliferation and metastasis of malignant melanoma by inducing the miR-125b-5p/EIF5A2 axis. Journal of Experimental & Clinical Cancer Research, 39(1), 1-16.

Lin, Y. M., Chen, M. L., Chen, C. L., Yeh, C. M., & Sung, W. W. (2020). Overexpression of EIF5A2 predicts poor prognosis in patients with oral squamous cell carcinoma. Diagnostics, 10(7), 436.

Liu, Y., Lei, P., Qiao, H., Sun, K., Lu, X., Bao, F., ... & Xue, F. (2019). miR-9 enhances the chemosensitivity of AML cells to daunorubicin by targeting the EIF5A2/MCL-1 axis. International journal of biological sciences, 15(3), 579.

Guan, X., Gu, S., Yuan, M., Zheng, X., & Wu, J. (2019). MicroRNA‑33a‑5p overexpression sensitizes triple‑negative breast cancer to doxorubicin by inhibiting eIF5A2 and epithelial‑mesenchymal transition. Oncology Letters, 18(6), 5986-5994.

Zheng, X., Gao, L., Wang, B. T., Shen, P., Yuan, X. F., Zhang, L. Q., ... & Wang, X. M. (2019). Overexpression of EIF5A2 is associated with poor survival and aggressive tumor biology in gallbladder cancer. Histology and Histopathology, 35(6), 579-587.

Yang, Y., Cui, H., & Wang, X. (2019). Downregulation of EIF5A2 by miR-221-3p inhibits cell proliferation, promotes cell cycle arrest and apoptosis in medulloblastoma cells. Bioscience, Biotechnology, and Biochemistry, 83(3), 400-408.

Sun, J., Xu, Z., Lv, H., Wang, Y., Wang, L., Ni, Y., ... & Cheng, X. (2018). eIF5A2 regulates the resistance of gastric cancer cells to cisplatin via induction of EMT. American journal of translational research, 10(12), 4269.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols

Related Products

Rabbit Anti-EIF5A2 Recombinant Antibody (CBFYE-0750)

Mouse Anti-EIF5A2 Recombinant Antibody (OTI6G7)

Mouse Anti-EIF5A2 Recombinant Antibody (1E7)

Mouse Anti-EIF5A2 (AA 1-154) Recombinant Antibody (PAT2E9AT)

Rabbit Anti-EIF5A2 Recombinant Antibody (CBFYE-0142)

Mouse Anti-EIF5A2 (AA 66-153) Recombinant Antibody (CBFYE-0751)

Isotype control